CLINICAL_TRIALS
trial_result
· 2022-03-02
Clinical Trial Update: Fostamatinib for Hospitalized Adults With COVID-19 [Phase 2]
Summary
Phase 2 trial update on fostamatinib for hospitalized adults with COVID-19; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Coronavirus Disease 2019 | Phase 2 | Status: COMPLETED | Results posted: 2022-03-02